IL-15 has also anti-tumorigenic effects; in fact, Carbo et al. (2000) showed that, in tumorigenic rats treated with IL-15, it partly inhibits skeletal muscle wasting protein rates (eight-fold) to values even lower than those observed in non-tumor-bearing animals. The gene discussed is IL15; the disease is neoplasm.